AM
Argá Medtech develops a cardiac ablation system that utilizes radiofrequency energy to precisely target and eliminate abnormal heart tissue responsible for arrhythmias. This technology enhances procedural efficiency and patient outcomes by reducing recovery time and minimizing complications associated with traditional ablation methods.
Updated 4 months ago
Funding
$70.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Argá Medtech develops a cardiac ablation system that utilizes radiofrequency energy to precisely target and eliminate abnormal heart tissue responsible for arrhythmias. This technology enhances procedural efficiency and patient outcomes by reducing recovery time and minimizing complications associated with traditional ablation methods.